Substituted quinolines and their use as mycobacterial inhibitors

Details for Australian Patent Application No. 2005206330 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Guillemont, Jerome Emile Georges; Pasquier, Elisabeth Therese Jeanne

Agent Shelston IP

Pub. Number AU-B-2005206330

PCT Pub. Number WO2005/070924

Priority 60/538,768 23.01.04 US

Filing date 21 January 2005

Wipo publication date 4 August 2005

Acceptance publication date 16 September 2010

International Classifications

C07D 413/06 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/070924 Priority application(s): WO2005/070924

16 September 2010 Application Accepted

  Published as AU-B-2005206330

20 January 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005206337-Process for the reactive extraction of levulinic acid

2005206311-Hinge for mounting in an opening